FCGRT
IgG receptor FcRn large subunit p51
Also known as: FcgammaRn, FCGRN_HUMAN, FcRn
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P55899
- Gene
- FCGRT
- Ensembl
- ENSG00000104870
- Chromosome
- 19
- Canonical length
- 365 aa
- Protein class
- FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a receptor that binds the Fc region of monomeric immunoglobulin G. The encoded protein transfers immunoglobulin G antibodies from mother to fetus across the placenta. This protein also binds immunoglobulin G to protect the antibody from degradation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2009]
Canonical amino-acid sequenceUniProt
365 residues, UniProt reviewed canonical sequence.
>P55899|FCGRT
1 MGVPRPQPWA LGLLLFLLPG SLGAESHLSL LYHLTAVSSP APGTPAFWVS GWLGPQQYLS
61 YNSLRGEAEP CGAWVWENQV SWYWEKETTD LRIKEKLFLE AFKALGGKGP YTLQGLLGCE
121 LGPDNTSVPT AKFALNGEEF MNFDLKQGTW GGDWPEALAI SQRWQQQDKA ANKELTFLLF
181 SCPHRLREHL ERGRGNLEWK EPPSMRLKAR PSSPGFSVLT CSAFSFYPPE LQLRFLRNGL
241 AAGTGQGDFG PNSDGSFHAS SSLTVKSGDE HHYCCIVQHA GLAQPLRVEL ESPAKSSVLV
301 VGIVIGVLLL TAAAVGGALL WRRMRSGLPA PWISLRGDDT GVLLPTPGEA QDADLKDVNV
361 IPATALocalizationUniProt · AlphaFold · HPA
Whether an antibody against FCGRT can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 395 nTPM
Expression across tissuesHPA
Tissue
- liver: 395 nTPM
- choroid plexus: 342 nTPM
- spleen: 315 nTPM
- duodenum: 286 nTPM
- small intestine: 282 nTPM
- adipose tissue: 258 nTPM
Single-cell type
- hofbauer cells: 2,332 nCPM
- enterocytes: 1,576 nCPM
- kupffer cells: 1,473 nCPM
- macrophages: 605 nCPM
- colonocytes: 601 nCPM
- paneth cells: 584 nCPM
Immune cell
- neutrophil: 2,360 nTPM
- classical monocyte: 1,368 nTPM
- total PBMC: 1,277 nTPM
- eosinophil: 1,015 nTPM
- myeloid DC: 924 nTPM
- intermediate monocyte: 907 nTPM
Brain region
- choroid plexus: 118 nTPM
- thalamus: 53 nTPM
- white matter: 49 nTPM
- hypothalamus: 43 nTPM
- medulla oblongata: 41 nTPM
- spinal cord: 40 nTPM
ReferencesPubMed · IEDB
Publications for FCGRT from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
5 publications
- Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis: Results From the Randomized Phase 2 Vivacity-MG Study.
2024 · Neurology · RCR 13.2 · 60 citations - Subcutaneous batoclimab in generalized myasthenia gravis: Results from a Phase 2a trial with an open-label extension.
2024 · Ann Clin Transl Neurol · RCR 3.3 · 15 citations - Pharmacokinetics and Pharmacodynamics of Nipocalimab, a Neonatal Fc Receptor Blocker, in Healthy Japanese Volunteers.
2024 · Clin Drug Investig · RCR 2.7 · 12 citations - Antineonatal Fc Receptor Antibody Treatment Ameliorates MOG-IgG-Associated Experimental Autoimmune Encephalomyelitis.
2022 · Neurol Neuroimmunol Neuroinflamm · RCR 2.2 · 23 citations - Efgartigimod improves muscle weakness in a mouse model for muscle-specific kinase myasthenia gravis.
2019 · Exp Neurol · RCR 1.5 · 30 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.69
- gnomAD pLI
- 0.04
- gnomAD missense Z
- 0.84
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- immune response
- IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Immunoglobulin/major histocompatibility complex, conserved site
- Immunoglobulin C1-set
- Immunoglobulin-like domain
- MHC class I-like antigen recognition-like
- MHC classes I/II-like antigen recognition protein
- Immunoglobulin-like fold
- Immunoglobulin-like domain superfamily
- MHC class I-like antigen recognition-like superfamily
- Antigen-presenting and immune regulatory MHC class I-related
- Class I Histocompatibility antigen, domains alpha 1 and 2
- Immunoglobulin C1-set domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FCGRT in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FCGRT as an antibody target. Whether an autoantibody or antibody against FCGRT could matter depends on whether native FCGRT is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FCGRT is annotated at the cell surface, where native FCGRT is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Source-annotated serology context
The source annotations explicitly mention antibody, autoantibody, autoantigen, or autoimmune context. This is biological context, not study-specific reactivity.
- The encoded protein transfers immunoglobulin G antibodies from mother to fetus across the placenta.
- This protein also binds immunoglobulin G to protect the antibody from degradation.
Loading the interactive Seroatlas protein explorer...